Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase
Authors:
- James L. SlackJSJames L. Slack
- Jose LeisJLJose Leis
- Roberta H. AdamsRARoberta H. Adams
- Craig B. ReederCRCraig B. Reeder
- Joseph R. MikhaelJMJoseph R. Mikhael
- John CamorianoJCJohn Camoriano
- Pierre NoelPNPierre Noel
- Veena FaubleVFVeena Fauble
- Jeffrey BetcherJBJeffrey Betcher
- Meagan S. HigginsMHMeagan S. Higgins
- Ginger Gillette-KentGGGinger Gillette-Kent
- 1 September 2012
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 36 (9) , 1147-1151
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasmBlood, 2010
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patientsHaematologica, 2008
- The natural history and treatment outcome of blast phase BCR-ABL− myeloproliferative neoplasmsBlood, 2008
- JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosisBlood, 2007
- Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patientsLeukemia, 2006
- Long-term Outcome of 231 Patients With Essential ThrombocythemiaArchives of internal medicine (1960), 2005
- Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyBlood, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 casesBlood, 2005